The European Commission has approved Johnson and Johnson’s Yuvanci for pulmonary arterial hypertension, offering the first single-pill treatment option to European patients. Credit: andreswd via
Iterum Therapeutics’s urinary tract infection antibiotic, oral sulopenem, is facing an FDA approval decision ahead of its 25 October PDUFA date. Credit: boonchai wedmakawand via
Cereno Scientific announced the upcoming release of a Phase II PAH readout in September 2024. Credit: Green Apple via Getty Images. There is a major
Senator Peter Welch declared a bill to curb restrictions on the 340B drug pricing programme. Credit: Bonnie Cash via Getty Images. Pharmaceutical manufacturers have been
At the ESC Congress, Dr. Milton Packer highlighted recent research into beta blocker treatment for myocardial infarction. Credit: luchschenF via Shutterstock. A shift in the
Caption: At the ESC Congress, the George Institute for Global Health presented positive data from a clinical trial investigating a single pill-combination for mild-to-moderate hypertension.
Dr. Jawad Haider Butt shared data demonstrating that a patient’s duration of living with type 2 diabetes does not impact treatment response to Forxiga. Credit:
Amvuttra showed a significant reduction in mortality and cardiovascular events for ATTR amyloidosis with cardiomyopathy patients in the Helios B trial. Credit: Tada Images via
Biomarin fired 225 employees as part of a major restructuring effort. Credit: SOPA Images via Getty Images. BioMarin Pharmaceuticals plans to let 225 staff members
AstraZeneca may move vaccine manufacturing facilities from the UK to the US, amid potential changes to state financial aid. Credit: Nathan Stirk via Getty Images.